| Sodium–glucose co‐transporter 2 inhibition with empagliflozin improves cardiac function in non‐diabetic rats with left ventricular dysfunction after myocardial infarction SR Yurista, HHW Silljé, SU Oberdorf‐Maass, EM Schouten, ... European journal of heart failure 21 (7), 862-873, 2019 | 324 | 2019 |
| Heart failure stimulates tumor growth by circulating factors WC Meijers, M Maglione, SJL Bakker, R Oberhuber, LM Kieneker, ... Circulation 138 (7), 678-691, 2018 | 323 | 2018 |
| Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization BD Westenbrink, E Lipšic, P van der Meer, P van der Harst, H Oeseburg, ... European heart journal 28 (16), 2018-2027, 2007 | 306 | 2007 |
| Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction J Tromp, BD Westenbrink, W Ouwerkerk, DJ van Veldhuisen, NJ Samani, ... Journal of the American College of Cardiology 72 (10), 1081-1090, 2018 | 282 | 2018 |
| Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate K Damman, DJ Van Veldhuisen, G Navis, VS Vaidya, TDJ Smilde, ... Heart 96 (16), 1297-1302, 2010 | 274 | 2010 |
| Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction G van Woerden, TM Gorter, BD Westenbrink, TP Willems, ... European journal of heart failure 20 (11), 1559-1566, 2018 | 254 | 2018 |
| A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study E Lipšic, P van der Meer, AA Voors, BD Westenbrink, ... Cardiovascular drugs and therapy 20, 135-141, 2006 | 233 | 2006 |
| Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well BD Westenbrink, FW Visser, AA Voors, TDJ Smilde, E Lipsic, G Navis, ... European heart journal 28 (2), 166-171, 2007 | 223 | 2007 |
| Levels of Hematopoiesis Inhibitor N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Partially Explain the Occurrence of Anemia in Heart Failure P van der Meer, E Lipsic, BD Westenbrink, RMA van de Wal, ... Circulation 112 (12), 1743-1747, 2005 | 209 | 2005 |
| Prognostic value of serial ST2 measurements in patients with acute heart failure LC van Vark, I Lesman-Leegte, SJ Baart, D Postmus, YM Pinto, JG Orsel, ... Journal of the American College of Cardiology 70 (19), 2378-2388, 2017 | 181 | 2017 |
| Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC State-of-the-Art Review SR Yurista, CR Chong, JJ Badimon, DP Kelly, RA de Boer, ... Journal of the American College of Cardiology 77 (13), 1660-1669, 2021 | 179 | 2021 |
| The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction C Withaar, LMG Meems, G Markousis-Mavrogenis, CJ Boogerd, ... Cardiovascular Research 117 (9), 2108-2124, 2021 | 175 | 2021 |
| Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure TDJ Smilde, K Damman, P van der Harst, G Navis, B Daan Westenbrink, ... Clinical Research in Cardiology 98, 121-129, 2009 | 158 | 2009 |
| Ketone ester treatment improves cardiac function and reduces pathologic remodeling in preclinical models of heart failure SR Yurista, TR Matsuura, HHW Silljé, KT Nijholt, KS McDaid, SV Shewale, ... Circulation: Heart Failure 14 (1), e007684, 2021 | 134 | 2021 |
| Bone marrow dysfunction in chronic heart failure patients BD Westenbrink, AA Voors, RA de Boer, JJ Schuringa, T Klinkenberg, ... European Journal of Heart Failure 12 (7), 676-684, 2010 | 132 | 2010 |
| Low‐dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit E Lipšic, BD Westenbrink, P van der Meer, P van der Harst, AA Voors, ... European journal of heart failure 10 (1), 22-29, 2008 | 109 | 2008 |
| Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure BD Westenbrink, WPT Ruifrok, AA Voors, RG Tilton, DJ Van Veldhuisen, ... Cardiovascular research 87 (1), 30-39, 2010 | 104 | 2010 |
| Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia BD Westenbrink, H Oeseburg, L Kleijn, P van der Harst, AMS Belonje, ... Cardiovascular drugs and therapy 22, 265-274, 2008 | 96 | 2008 |
| Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE‐LY trial BD Westenbrink, M Alings, SJ Connolly, J Eikelboom, MD Ezekowitz, ... Journal of Thrombosis and Haemostasis 13 (5), 699-707, 2015 | 80 | 2015 |
| CaMKIIδ subtypes differentially regulate infarct formation following ex vivo myocardial ischemia/reperfusion through NF-κB and TNF-α CBB Gray, T Suetomi, S Xiang, S Mishra, EA Blackwood, CC Glembotski, ... Journal of molecular and cellular cardiology 103, 48-55, 2017 | 79 | 2017 |
